Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)

PHASE4CompletedINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Asthma
Interventions
DRUG

Salmeterol/ fluticasone propionate

2 active arms (parellel group)

Trial Locations (12)

431-070

GSK Investigational Site, Anyang-si

Unknown

GSK Investigational Site, Busan

GSK Investigational Site, Jeonju

GSK Investigational Site, Junjoo-Si

GSK Investigational Site, Kyungki-Do Anyang-si

GSK Investigational Site, Kyungki-Do

GSK Investigational Site, Pusan

GSK Investigational Site, Seoul

602-739

GSK Investigational Site, Pusan

120-752

GSK Investigational Site, Seoul

140-743

GSK Investigational Site, Seoul

152-703

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY